Skip to main content
Journal of Experimental Orthopaedics

Table 1 Pharmacy insurance claims

From: Hormone replacement therapy does not increase thrombosis risk following THA: a national database study

Hormone Replacement Therapy

GENERIC_DRUG-DROSPIRENONE/ESTRADIOL, GENERIC_DRUG-ETHINYL_ESTRADIOL/DROSPIRENONE, GENERIC_DRUG-DESOGESTREL-ETHINYL_ESTRADIOL, GENERIC_DRUG-DROSPIR/ETH_ESTRA/LEVOMEFOL_CA, GENERIC_DRUG-ETHYNODIOL_D-ETHINYL_ESTRADIOL, GENERIC_DRUG-LEVONORGESTREL-ETHIN_ESTRADIOL, GENERIC_DRUG-LEVONORGESTREL/ETHIN.ESTRADIOL, GENERIC_DRUG-ESTRADIOL/LEVONORGESTREL, GENERIC_DRUG-NORGESTIMATE-ETHINYL_ESTRADIOL, GENERIC_DRUG-ESTRADIOL/NORGESTIMATE

  1. Pharmacy claims data were queried to identify patients taking HRT prior to surgery. Patients were placed in the test cohort if they were prescribed any of these drugs within 12 months of undergoing primary THA
Back to article page